Skip to content
Preprint · CC-BY via OpenAlex

Preclinical Evaluation of mTORC1 Inhibition via Rapamycin in Machine-Perfused Rodent Livers

Christopher Taveras, Alissa M. Cutrone, Emmanuella O. Ajenu, Madeeha Hassan, Alban Longchamp, Shannon N. Tessier, Korkut Uygun, Heidi Yeh

Research Square · 2025 · ▲ 1 citations

Abstract

Abstract Normothermic machine perfusion (NMP) enables real-time liver viability assessment and therapeutic intervention during preservation. mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">Rapamycin(definition), an mTORC1 inhibitor known to induce autophagy(definition) and promote cellular resilience, represents a promising candidate for mitigating ischemic injury during NMP. We developed a rat model of warm ischemia followed by NMP to evaluate whether rapamycin improves liver graft quality. Livers were subjected to 90 minutes of warm ischemia and then perfused for three hours with or without 50nM rapamycin. While no significant differences were observed in perfusate oxygen consumption, lactate clearance, or transaminase release, histological analysis revealed that rapamycin-treated livers had improved cellular architecture and reduced necrosis compared to untreated controls. These findings suggest that rapamycin may confer structural protection independent of immediate metabolic changes. This model provides a platform to further study targeted therapies during NMP and supports the potential role of mTORC1 modulation in enhancing liver graft preservation.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.21203/rs.3.rs-7340727/v1
Canonical
link ↗
Fetched
2026-11-15 MST

Cite this

APA
Taveras, C., Cutrone, A.M., Ajenu, E.O., Hassan, M., Longchamp, A., Tessier, S.N., Uygun, K., &amp; Yeh, H. (2025). Preclinical Evaluation of mTORC1 Inhibition via Rapamycin in Machine-Perfused Rodent Livers. <em>Research Square</em>. https://doi.org/10.21203/rs.3.rs-7340727/v1
Vancouver
Taveras C, Cutrone AM, Ajenu EO, Hassan M, Longchamp A, Tessier SN, et al. Preclinical Evaluation of mTORC1 Inhibition via Rapamycin in Machine-Perfused Rodent Livers. Research Square. 2025. doi:10.21203/rs.3.rs-7340727/v1.
BibTeX
@unpublished{christopher2025Precli, title = {Preclinical Evaluation of mTORC1 Inhibition via Rapamycin in Machine-Perfused Rodent Livers}, author = {Christopher Taveras and Alissa M. Cutrone and Emmanuella O. Ajenu and Madeeha Hassan and Alban Longchamp and Shannon N. Tessier and Korkut Uygun and Heidi Yeh}, journal = {Research Square}, year = {2025}, doi = {10.21203/rs.3.rs-7340727/v1}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings